Pulmonary function decreases moderately after accelerated high-dose irradiation for stage III non-small cell lung cancer.

This study shows that high-dose irradiation delivered with intensity-modulated techniques does not impair short-term lung function even in patients with compromised respiratory capacity before treatment. This is a pre-requisite for adequate quality of life after thoraco-oncological therapy.